Frequency and Clinical Patterns of Placental Abruption and Placenta Previa in Pregnant Women at Tertiary Care Hospital Quetta
DOI:
https://doi.org/10.61919/6q5n7m27Keywords:
Antepartum hemorrhage, placental abruption, placenta previa, hypertension, maternal outcome, fetal outcome, Quetta.Abstract
Background: Antepartum hemorrhage remains a major cause of maternal and perinatal morbidity in low-resource obstetric settings, particularly where hypertensive disorders, grand multiparity, delayed referral, and inadequate antenatal screening coexist. Placental abruption and placenta previa are the two principal causes, but their frequency and clinical patterns vary across populations. Objective: To determine the frequency and clinical patterns of placental abruption and placenta previa and to compare their maternal and fetal outcomes among pregnant women presenting to a tertiary care hospital in Quetta. Methods: This cross-sectional study was conducted in the Department of Gynecology and Obstetrics, Bolan Medical College/Hospital, Quetta, from May to August 2025. A total of 154 pregnant women beyond 28 weeks of gestation with antepartum hemorrhage due to placental abruption or placenta previa were enrolled consecutively. Diagnosis was based on clinical assessment supported by ultrasonography. Data were analyzed using SPSS version 26.0 with descriptive statistics and chi-square-based comparisons. Results: Placental abruption accounted for 95 cases (61.7%) and placenta previa for 59 cases (38.3%). Hypertension was significantly more common in placental abruption (61.1% vs 15.3%; OR 8.71, 95% CI 3.83–19.79). Blood transfusion requirement (86.3% vs 67.8%), fetal distress or bradycardia (65.3% vs 20.3%), and intrauterine death (18.9% vs 3.4%) were substantially higher in abruption. All previa cases required cesarean delivery, whereas 74.7% of abruption cases underwent cesarean section. Overall maternal mortality was 1.3%. Conclusion: Placental abruption was more frequent than placenta previa in this tertiary care cohort and was associated with markedly greater maternal and fetal compromise. Strengthening antenatal hypertension surveillance, early placental localization, and timely referral may reduce preventable adverse outcomes.
References
1. Roberge S, Bujold E, Nicolaides KH. Meta-analysis on the effect of aspirin use for prevention of preeclampsia on placental abruption and antepartum hemorrhage. Am J Obstet Gynecol. 2018;218(5):483-489. doi:10.1016/j.ajog.2017.12.238.
2. Fadl SA, Linnau KF, Dighe MK. Placental abruption and hemorrhage: review of imaging appearance. Emerg Radiol. 2019;26(1):87-97. doi:10.1007/s10140-018-1638-3.
3. Hofmeyr GJ, Qureshi Z. Preventing deaths due to hemorrhage. Best Pract Res Clin Obstet Gynaecol. 2016;36:68-82. doi:10.1016/j.bpobgyn.2016.05.004.
4. Latif E, Adam S, Rung-Ruang B, Al-Hendy A, Diamond MP, Rotem E, et al. Use of uterine artery embolization to prevent peripartum hemorrhage of placental abruption with fetal demise and severe DIC. J Neonatal Perinatal Med. 2016;9(3):325-331. doi:10.3233/NPM-16915108.
5. Skeith L, Rodger M. Anticoagulants to prevent recurrent placenta-mediated pregnancy complications: is it time to put the needles away? Thromb Res. 2017;151 Suppl 1:S38-S42. doi:10.1016/S0049-3848(17)30065-8.
6. Qin J, Liu X, Sheng X, Wang H, Gao S. Assisted reproductive technology and the risk of pregnancy-related complications and adverse pregnancy outcomes in singleton pregnancies: a meta-analysis of cohort studies. Fertil Steril. 2016;105(1):73-85.e1-6. doi:10.1016/j.fertnstert.2015.09.007.
7. Magann EF, Dinnel KI, Rabie NZ, Shoemaker AL, Manning NA. Intra-amniotic hemorrhage imitating gastroschisis: a case report and review of the literature. Am J Case Rep. 2016;17:766-769. doi:10.12659/AJCR.900114.
8. Friedman AM, Wright JD, Ananth CV, Siddiq Z, D'Alton ME, Bateman BT. Population-based risk for peripartum hysterectomy during low- and moderate-risk delivery hospitalizations. Am J Obstet Gynecol. 2016;215(5):640.e1-640.e8. doi:10.1016/j.ajog.2016.06.032.
9. Zhong QY, Gelaye B, Smoller JW, Vilchez P, Cai T, Williams MA. Adverse obstetric outcomes during delivery hospitalizations complicated by suicidal behavior among US pregnant women. PLoS One. 2018;13(2):e0192943. doi:10.1371/journal.pone.0192943.
10. Ahmadzia HK, Phillips JM, James AH, Rice MM, Amdur RL. Predicting peripartum blood transfusion in women undergoing cesarean delivery: a risk prediction model. PLoS One. 2018;13(12):e0208417. doi:10.1371/journal.pone.0208417.
11. Zhong QY, Gelaye B, Fricchione GL, Vilchez P, Karlson EW, Williams MA. Adverse obstetric and neonatal outcomes complicated by psychosis among pregnant women in the United States. BMC Pregnancy Childbirth. 2018;18(1):120. doi:10.1186/s12884-018-1750-0.
12. Reddy UM, Rice MM, Grobman WA, Bailit JL, Wapner RJ, Varner MW, et al. Serious maternal complications after early preterm delivery (24-33 weeks' gestation). Am J Obstet Gynecol. 2015;213(4):538.e1-9. doi:10.1016/j.ajog.2015.06.064.
13. Ruiter-Ligeti J, Cuzzi-Shulman N, Spence AR, Tulandi T, Abenhaim HA. Pregnancy outcomes in women with osteogenesis imperfecta: a retrospective cohort study. J Perinatol. 2016;36(10):828-831. doi:10.1038/jp.2016.111.
14. Shinde GR, Vaswani BP, Patange RP, Ladda MM, Bhosale RB. Diagnostic performance of ultrasonography for detection of abruption and its clinical correlation and maternal and fetal outcome. J Clin Diagn Res. 2016;10(8):QC04-QC07. doi:10.7860/JCDR/2016/19247.8288.
15. Stanek J. Placental examination in nonmacerated stillbirth versus neonatal mortality. J Perinat Med. 2018;46(3):323-331. doi:10.1515/jpm-2017-0198.
16. Crane JM, Magee LA, Lee T, Synnes A, von Dadelszen P, Dahlgren L, et al. Maternal and perinatal outcomes of pregnancies delivered at 23 weeks' gestation. J Obstet Gynaecol Can. 2015;37(3):214-224. doi:10.1016/S1701-2163(15)30307-8.
17. Sharon R, Zilber O, Amichai K, Wiser A, Kidron D, Biron-Shental T, et al. The magnitude of elevated maternal serum human chorionic gonadotropin and pregnancy complications. J Obstet Gynaecol. 2017;37(5):576-579. doi:10.1080/01443615.2016.1268578.
18. Bell JE, Becher JC, Keeling JW, McIntosh N. The neuropathology of stillbirth: correlation with apolipoprotein genotype in a Scottish population-based study. Early Hum Dev. 2015;91(2):139-148. doi:10.1016/j.earlhumdev.2014.12.008.
19. Lazo-Langner A, Al-Ani F, Weisz S, Rozanski C, Louzada M, Kovacs J, et al. Prevention of venous thromboembolism in pregnant patients with a history of venous thromboembolic disease: a retrospective cohort study. Thromb Res. 2018;167:20-25. doi:10.1016/j.thromres.2018.05.005.
20. Kang E, Sugarman R, Ramadan H, Mueller A, Shahul S, Perdigao JL, et al. Prevalence, risk factors and associated complications of postpartum hypertension in rural Haiti. Pregnancy Hypertens. 2017;10:135-142. doi:10.1016/j.preghy.2017.07.143.
21. Rodgers R, Beik N, Nassar N, Brito I, de Vries B. Complications of external cephalic version: a retrospective analysis of 1121 patients at a tertiary hospital in Sydney. BJOG. 2017;124(5):767-772. doi:10.1111/1471-0528.14169.
22. Hofmeyr GJ, Qureshi Z. Preventing deaths due to hemorrhage. Best Pract Res Clin Obstet Gynaecol. 2016;36:68-82. doi:10.1016/j.bpobgyn.2016.05.004.
23. Matsubara S, Takahashi H, Matsubara D, Baba Y. Delivery or previous cesarean? A comment on “Antepartum hemorrhage from previous-cesarean-sectioned uterus as a potential sign of uterine artery pseudoaneurysm”. J Zhejiang Univ Sci B. 2017;18(8):723-724. doi:10.1631/jzus.B1700241.
24. Durmaz A, Kocuroglu N. Relationship between maternal characteristics and postpartum hemorrhage: a meta-analysis study. J Nurs Res. 2018;26(5):362-372. doi:10.1097/JNR.0000000000000245.
25. Lu E, Shatzel JJ, Salati J, DeLoughery TG. The safety of low-molecular-weight heparin during and after pregnancy. Obstet Gynecol Surv. 2017;72(12):721-729. doi:10.1097/OGX.0000000000000505.
26. Sharma KJ, Kilpatrick SJ. Postpartum hypertension: etiology, diagnosis, and management. Obstet Gynecol Surv. 2017;72(4):248-252. doi:10.1097/OGX.0000000000000424.
27. Fogerty AE. Challenges of anticoagulation therapy in pregnancy. Curr Treat Options Cardiovasc Med. 2017;19(10):76. doi:10.1007/s11936-017-0575-x.
28. Riveros-Perez E, Kacmar R. Peripartum care of the Jehovah's Witness patient. Clin Obstet Gynecol. 2017;60(2):394-404. doi:10.1097/GRF.0000000000000271.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Amna Khan, Sumaira Hamza, Zoofishan Suleman, Farzana Gul, Khalida Rehmat, Farah Fatima (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
